EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: A case report

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 5, 2009, Pages 548-550

  Iyevleva, Aglaya G ^a   Novik, Alexey V ^a   Moiseyenko, Vladimir M ^a   Imyanitov, Evgeny N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

EGFR; Erlotinib; Gefitinib; Mutation; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; INTERLEUKIN 2; TAMOXIFEN;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER GRADING; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CLEAR CELL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DRUG SENSITIVITY; DYSPNEA; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; PERICARDITIS; PLEURISY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DRUG RESISTANCE, NEOPLASM; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TAMOXIFEN;

EID: 69249154741     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.03.022     Document Type: Article

References (12)

1. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
2. Paez J.G., Janne P.A., Lee J.C., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
3. Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 (2004) 13306-13311
4. Lee J.W., Soung Y.H., Kim S.Y., et al. Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. Int J Cancer 113 (2005) 510-511
5. Franco-Hernandez C., Martinez-Glez V., Arjona D., et al. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors. Cancer Genet Cytogenet 173 (2007) 63-67
6. Sakaeda T., Okamura N., Gotoh A., et al. EGFR mRNA is up-regulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients. Pharm Res 22 (2005) 1757-1761
7. Little S.E., Bax D.A., Rodriguez-Pinilla M., et al. Multifaceted dysregulation of the epidermal growth factor receptor pathway in clear cell sarcoma of the kidney. Clin Cancer Res 13 (2007) 4360-4364
8. Yamaguchi H., Soda H., Kitazaki T., et al. Thymic carcinoma with epidermal growth factor receptor gene mutations. Lung Cancer 52 (2006) 261-262
9. Imyanitov E.N., and Moiseyenko V.M. Molecular-based choice of cancer therapy: Realities and expectations. Clin Chim Acta 379 (2007) 1-13
10. Greenman C., Stephens P., Smith R., et al. Patterns of somatic mutation in human cancer genomes. Nature 446 (2007) 153-158
11. Costa L.J., and Drabkin H.A. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist 12 (2007) 1404-1415
12. Chabner B.A., and Roberts Jr. T.G. Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer 5 (2005) 65-72